One of the most common questions community pharmacists receive from new mothers is whether a medicine is safe to take while breastfeeding. The concern is understandable — most patient information leaflets either advise against use during breastfeeding or provide ambiguous guidance that leaves mothers uncertain.
In practice, the majority of commonly used medicines are considered compatible with breastfeeding, and unnecessary avoidance of treatment can itself pose a risk to maternal health. The UK Drugs in Lactation Advisory Service (UKDILAS) and the Breastfeeding Network's factsheets are the authoritative resources pharmacists should consult.
The evidence landscape
Drug transfer into breast milk depends on several pharmacokinetic factors: molecular weight, protein binding, lipid solubility, ionisation, and maternal plasma concentration. For most medicines, the infant dose received via breast milk is less than 1% of the maternal dose — a threshold widely regarded as clinically insignificant.
The BNF and the Specialist Pharmacy Service (SPS) both provide breastfeeding-specific monographs. Where the evidence base is limited (as it often is, since lactating women are routinely excluded from clinical trials), expert assessment of pharmacokinetic properties and clinical experience guides the recommendation.
Common OTC medicines and breastfeeding
| Medicine | Breastfeeding compatible? | Notes |
|---|---|---|
| Paracetamol | Yes | First-line analgesic/antipyretic. Negligible transfer to milk. |
| Ibuprofen | Yes | Preferred NSAID in breastfeeding. Very low milk transfer due to high protein binding. |
| Aspirin (low-dose) | Caution | Low-dose (75mg) cardiovascular prophylaxis is generally acceptable. Avoid high analgesic doses. |
| Loratadine | Yes | Preferred antihistamine. Non-sedating, low milk transfer. |
| Cetirizine | Yes | Also acceptable. Non-sedating. |
| Chlorphenamine | Caution | Sedating antihistamine — may cause drowsiness in infant. Use non-sedating alternatives first. |
| Omeprazole | Yes | Negligible transfer. Short-term use for reflux is acceptable. |
| Loperamide | Yes | Poorly absorbed systemically. Minimal milk transfer. |
| Fluconazole | Yes | Used to treat maternal and infant thrush. Compatible at standard doses. |
| Hydrocortisone cream | Yes | Topical corticosteroids are safe. Avoid application directly on the nipple before feeding. |
Prescription medicines: key considerations
Antibiotics
Most commonly prescribed antibiotics are compatible with breastfeeding:
- Amoxicillin, flucloxacillin, erythromycin, cefalexin: all considered safe. Small amounts transfer to milk but are unlikely to cause adverse effects in the infant beyond possible loose stools.
- Metronidazole: compatible at standard doses. Earlier concerns about taste alteration in milk are not clinically significant.
- Ciprofloxacin: generally avoided during breastfeeding due to theoretical risk of cartilage effects in the infant, though short courses are considered low-risk by SPS.
- Doxycycline: short courses (up to 7 days) are acceptable. The calcium in milk chelates tetracyclines, reducing absorption by the infant.
Antidepressants
Postnatal depression affects approximately 10–15% of women, and untreated maternal mental illness poses significant risks to both mother and child. The key message for pharmacists: most SSRIs are compatible with breastfeeding.
- Sertraline: the preferred SSRI in breastfeeding. Very low relative infant dose (typically <2%).
- Paroxetine: also acceptable. Low milk transfer.
- Fluoxetine: less preferred due to longer half-life and higher relative infant dose, but not contraindicated.
- Citalopram/escitalopram: acceptable but sertraline is first-line.
Pharmacists should reassure mothers that the benefits of treating depression overwhelmingly outweigh the minimal risks of SSRI exposure through breast milk.
Analgesics
- Codeine: use with caution. Some women are ultra-rapid CYP2D6 metabolisers, converting codeine to morphine faster than average — this can produce dangerously high morphine levels in breast milk. The MHRA issued a safety alert in 2013 advising against codeine use in breastfeeding mothers. Pharmacists should recommend paracetamol or ibuprofen as first-line alternatives.
- Tramadol: similar concerns to codeine. Avoid where possible.
- Morphine: acceptable for short-term use (e.g., post-operative pain) as infant exposure via milk is low. Monitor infant for sedation.
When to refer
Pharmacists should refer breastfeeding mothers to a GP or specialist when:
- The medicine in question has limited breastfeeding data and the clinical need is ongoing
- The infant is premature (premature infants metabolise drugs less efficiently)
- The mother is on a complex regimen (e.g., anticonvulsants, immunosuppressants, biological medicines)
- The infant shows signs of adverse effects: unusual drowsiness, poor feeding, rash, or irritability
The pharmacist's role
Community pharmacists see breastfeeding mothers frequently — for prescriptions, OTC purchases, and general health advice. The renewed Women's Health Strategy announced by DHSC on 14 April 2026, which aims to improve how the healthcare system serves women, reinforces the importance of accessible, evidence-based advice at every touchpoint.
The most common pharmacist intervention is reassurance: telling a mother that the medicine she needs is safe to take while breastfeeding, and that she does not need to choose between treatment and feeding. This reassurance, grounded in evidence, is a genuine clinical service.
Explore pharmacy services near you or pharmacy career opportunities on PharmSee.
Sources: BNF breastfeeding guidance, Specialist Pharmacy Service (SPS) monographs, UK Drugs in Lactation Advisory Service, Breastfeeding Network factsheets, MHRA codeine safety alert 2013, DHSC Women's Health Strategy 2026, PharmSee vacancy database.